Bendamustine-based Combination Therapy for PCNSL
NCT03392714
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
PCNSL
Interventions
DRUG:
R-B(O)AD
Sponsor
Chonnam National University Hospital